Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
| ▸ | MC4R | P32245 | 2/20 | 0.50 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.49 |
| ▸ | CTSL | P07711 | 3/20 | 0.49 |
| ▸ | CTSS | P25774 | 3/20 | 0.49 |
| ▸ | CTSK | P43235 | 3/20 | 0.49 |
| ▸ | CTSH | P09668 | 1/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.48 |
| ▸ | CCKAR | P32238 | 1/20 | 0.47 |
| ▸ | CCKBR | P32239 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.47 |
| ▸ | GLP1R | P43220 | 1/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30264772 | 0.98 | C5AR1 (0.51) | C5AR1MC4RKISS1RCTSLCTSS | |
| SCHEMBL29476562 | 0.95 | MC4R (0.50) | C5AR1MC4RKISS1R | |
| SCHEMBL29476617 | 0.95 | MC4R (0.50) | C5AR1MC4RKISS1R | |
| SCHEMBL29511100 | 0.94 | C5AR1 (0.51) | C5AR1MC4RKISS1RCTSLCTSS | |
| SCHEMBL30725657 | 0.94 | C5AR1 (0.52) | C5AR1MC4RIL23RNPBWR1GLP1R | |
| SCHEMBL29511047 | 0.93 | C5AR1 (0.50) | C5AR1MC4RCCKBR | |
| SCHEMBL30510423 | 0.91 | TUBB4A (0.52) | C5AR1MC4RKISS1RCTSLCTSS | |
| SCHEMBL29476494 | 0.91 | TUBB4A (0.52) | C5AR1MC4RKISS1RCTSLCTSS | |
| SCHEMBL30518049 | 0.91 | C5AR1 (0.53) | C5AR1MC4RKISS1RCTSLCTSS | |
| SCHEMBL30264643 | 0.91 | IL23R (0.54) | MC4RKISS1RIL23RNPBWR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | MC3R, MC1R, MC5R | C5AR1 72/4885MC4R 4/4885KISS1R 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.